美股異動丨輝瑞升逾3% Q1經調整每股盈利遠超預期擴大成本削減力度

格隆匯APP

2025/04/29

格隆匯4月29日｜輝瑞(PFE.US)升逾3%，報23.755美元。消息面上，輝瑞周二公布，在加大成本削減力度下，首季淨利潤按年跌約5%至29.7億美元，經調整每股盈利92美仙，遠高於市場預期的66美仙；營收按年跌8%至137.2億美元，反映其抗病毒藥物Paxlovid的收入減少。公司預計，通過兩項成本削減措施，到2027年底將節省約77億美元。公司維持對2025年全年財報的預期，預計銷售額為610億至640億美元，惟補充該指引目前不包括與未來關稅和貿易政策變化相關的任何潛在影響。

海量資訊、精準解讀，盡在新浪財經APP

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2531757594"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2531757594\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2531757594?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2025-04-29 23:11","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2531757594","market":"other","top_or_hot":-1,"title":"美股異動丨輝瑞升逾3% Q1經調整每股盈利遠超預期 擴大成本削減力度","media":"格隆匯APP","content":"<html><body><div>\n<p cms-style=\"font-L\"><font cms-hidden=\"true\" cms-style=\"font-L\"></font>    格隆匯4月29日｜<a href=\"https://laohu8.com/S/PFE\">輝瑞</a>(PFE.US)升逾3%，報23.755美元。消息面上，輝瑞周二公布，在加大成本削減力度下，首季淨利潤按年跌約5%至29.7億美元，經調整每股盈利92美仙，遠高於市場預期的66美仙；營收按年跌8%至137.2億美元，反映其抗病毒藥物Paxlovid的收入減少。公司預計，通過兩項成本削減措施，到2027年底將節省約77億美元。公司維持對2025年全年財報的預期，預計銷售額為610億至640億美元，惟補充該指引目前不包括與未來關稅和貿易政策變化相關的任何潛在影響。</p><div><img src=\"http://n.sinaimg.cn/spider20250429/442/w699h543/20250429/ff58-ad5a3ca88f1c888d19e9e7aa80b21d87.jpg\"/><span></span></div>\n<div></div>\n<div>\n<div><img src=\"\"/></div>\n<div>海量資訊、精準解讀，盡在新浪財經APP</div>\n</div>\n</div></body></html>","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>美股異動丨輝瑞升逾3% Q1經調整每股盈利遠超預期 擴大成本削減力度</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n美股異動丨輝瑞升逾3% Q1經調整每股盈利遠超預期 擴大成本削減力度\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">格隆匯APP</strong><span class=\"h-time small\">2025-04-29 23:11</span>\n</p>\n</h4>\n</header>\n<article>\n<html><body><div>\n<p cms-style=\"font-L\"><font cms-hidden=\"true\" cms-style=\"font-L\"></font>    格隆匯4月29日｜<a href=\"https://laohu8.com/S/PFE\">輝瑞</a>(PFE.US)升逾3%，報23.755美元。消息面上，輝瑞周二公布，在加大成本削減力度下，首季淨利潤按年跌約5%至29.7億美元，經調整每股盈利92美仙，遠高於市場預期的66美仙；營收按年跌8%至137.2億美元，反映其抗病毒藥物Paxlovid的收入減少。公司預計，通過兩項成本削減措施，到2027年底將節省約77億美元。公司維持對2025年全年財報的預期，預計銷售額為610億至640億美元，惟補充該指引目前不包括與未來關稅和貿易政策變化相關的任何潛在影響。</p><div><img src=\"http://n.sinaimg.cn/spider20250429/442/w699h543/20250429/ff58-ad5a3ca88f1c888d19e9e7aa80b21d87.jpg\"/><span></span></div>\n<div></div>\n<div>\n<div><img src=\"\"/></div>\n<div>海量資訊、精準解讀，盡在新浪財經APP</div>\n</div>\n</div></body></html>\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"https://finance.sina.com.cn/stock/bxjj/2025-04-29/doc-ineuwcvn0721829.shtml\">格隆匯APP</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SG9999011175.SGD","symbol_name":"Nikko AM Global Dividend Equity Dis SGD-H","start_time":0,"source_url":"https://finance.sina.com.cn/stock/bxjj/2025-04-29/doc-ineuwcvn0721829.shtml","article_id":"2531757594","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2531757594","pubTimestamp":1745939460,"columns":[],"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"格隆匯4月29日｜輝瑞(PFE.US)升逾3%，報23.755美元。消息面上，輝瑞周二公布，在加大成本削減力度下，首季淨利潤按年跌約5%至29.7億美元，經調整每股盈利92美仙，遠高於市場預期的66美仙；營收按年跌8%至137.2億美元，反映其抗病毒藥物Paxlovid的收入減少。公司預計，通過兩項成本削減措施，到2027年底將節省約77億美元。公司維持對2025年全年財報的預期，預計銷售額為610億至640億美元，惟補充該指引目前不包括與未來關税和貿易政策變化相關的任何潛在影響。\n\n\n\n海量資訊、精準解讀，盡在新浪財經APP","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"SG9999011175.SGD":"Nikko AM Global Dividend Equity Dis SGD-H","BK4592":"伊斯兰概念","SG9999003800.SGD":"Nikko AM Global Dividend Equity Acc SGD-H","LU0321505868.SGD":"Schroder ISF Global Dividend Maximiser A Dis SGD","SG9999013999.USD":"UOB UNITED GLOBAL HEALTHCARE FUND (USDHDG) INC","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","SG9999001176.SGD":"UOB UNITED GLOBAL HEALTHCARE \"SGD\" (ACC)","LU0321505439.SGD":"Schroder ISF Global Dividend Maximiser A Acc SGD","LU0234572021.USD":"高盛美国核心股票组合Acc","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","PFE":"辉瑞","SGXZ57979304.SGD":"United Global Healthcare A Acc SGD-H","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","IE000M9KFDE8.USD":"NEUBERGER BERMAN US LARGE CAP VALUE \"A\" (USD) ACC","LU0225284248.USD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" ACC","BK4588":"碎股","LU0985481810.HKD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" (HKD) INC M","BK4568":"美国抗疫概念","BK4550":"红杉资本持仓","LU0456855351.SGD":"JPMorgan Funds - Global Equity A (acc) SGD","LU0058720904.USD":"联博国际健康护理基金A","LU1894683264.USD":"AMUNDI FUNDS US EQUITY RESEARCH VALUE \"A2\" (USD) ACC","BK4007":"制药","SG9999001176.USD":"United Global Healthcare Acc USD","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU1066051498.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (USD) INC","LU1894683348.USD":"AMUNDI FUNDS US EQUITY RESEARCH VALUE \"A2\" (USD) INC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","IE00BLSP4239.USD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis USD Plus","BK4581":"高盛持仓","IE00BLSP4452.SGD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis SGD-H Plus","BK4599":"减肥药","SG9999002232.USD":"Allianz Global High Payout USD","LU0122379950.USD":"贝莱德世界健康科学A2","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","BK4585":"ETF&股票定投概念","LU0306807586.USD":"SCHRODER ISF GLOBAL DIVIDEND MAXIMISER \"A\" (USD) INC QF","BK4534":"瑞士信贷持仓","LU1883839398.USD":"AMUNDI FUNDS INCOME OPPORTUNITIES \"A2\" (USD) ACC","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","LU0306806265.USD":"SCHRODER ISF GLOBAL DIVIDEND MAXIMISER \"A\" ACC","SG9999002224.SGD":"Allianz Global High Payout SGD","LU0225771236.USD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" (USD) INC MF","BK4533":"AQR资本管理(全球第二大对冲基金)","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD"},"translate_title":"Changes in U.S. stocks | Pfizer rose more than 3% Q1 adjusted earnings per share far exceeded expectations and expanded cost reduction efforts","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PFE":1},"content_text":"格隆匯4月29日｜輝瑞(PFE.US)升逾3%，報23.755美元。消息面上，輝瑞周二公布，在加大成本削減力度下，首季淨利潤按年跌約5%至29.7億美元，經調整每股盈利92美仙，遠高於市場預期的66美仙；營收按年跌8%至137.2億美元，反映其抗病毒藥物Paxlovid的收入減少。公司預計，通過兩項成本削減措施，到2027年底將節省約77億美元。公司維持對2025年全年財報的預期，預計銷售額為610億至640億美元，惟補充該指引目前不包括與未來關税和貿易政策變化相關的任何潛在影響。\n\n\n\n海量資訊、精準解讀，盡在新浪財經APP","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}

美股異動丨輝瑞升逾3% Q1經調整每股盈利遠超預期 擴大成本削減力度

熱議股票

美股異動丨輝瑞升逾3% Q1經調整每股盈利遠超預期擴大成本削減力度